Full Text View
Tabular View
No Study Results Posted
Related Studies
Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer
This study has been completed.
Study NCT00001228   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: September 7, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Islet Cell Adenoma
Zollinger Ellison Syndrome
Additional conditions recognized in this trial
Adenoma
Adenoma, Islet Cell
Gastrinoma
Syndrome
Zollinger-Ellison Syndrome
More general conditions related to this trial
Adenocarcinoma
Carcinoma
Carcinoma, Islet Cell
Digestive System Diseases
Digestive System Neoplasms
Disease
Endocrine Gland Neoplasms
Endocrine System Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Pancreatic Diseases
Pancreatic Neoplasms
Paraneoplastic Endocrine Syndromes
Paraneoplastic Syndromes
Pathologic Processes
Peptic Ulcer
Stomach Diseases
Interventions listed in this trial
Interferon
Additional drug interventions recognized in this trial
Interferons
Octreotide
More general drug interventions related to this trial
Anti-Infective Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antiviral Agents
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services